The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global intracranial pressure monitoring market reached a value of US$ 1.39 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Intracranial pressure (ICP) monitoring is utilized in neurosurgery and neurology for measuring the pressure inside the skull. It can be performed using either invasive or non-invasive techniques. Amongst these, invasive techniques, such as ventriculostomy and micro transducers, involve drilling a hole in the skull using a burr hole or a twist drill technique for inserting the device. The device is connected to transducers for sending measurements and projecting cerebrospinal fluid (CSF) waveform. On the other hand, non-invasive techniques are generally utilized for avoiding complications of hemorrhages and infections associated with the former technique. They include transcranial Doppler, tympanic membrane displacement, optic nerve sheath diameter, magnetic resonance imaging (MRI) and fundoscopy. Nowadays, health professionals prefer using ICP monitors, clinical examination, and brain imaging to provide better results.
Owing to the increasing cases of coronavirus disease (COVID-19), the need for providing optimum care to patients under critical conditions is escalating around the world. This, in turn, is strengthening the ICP monitor market growth, as these devices are used for monitoring patients under intensive care. Apart from this, the rising number of individuals suffering from traumatic brain injury (TBI), represents another growth-inducing factor impelling market growth. Additionally, the increasing prevalence of autoimmune, cardiovascular and sleep disorders has catalyzed the demand for ICT monitors to provide early and effective treatment. Furthermore, governments of several countries are spending on improving the healthcare infrastructure and critical care centers, which is expected to boost the sales of these monitors. Additionally, manufacturers are also focusing on the introduction of an ICP monitoring device for home use. Such innovations are expected to create a positive outlook for the market growth in the coming years.
Breakup by Product Type:
Breakup by Technology:
Breakup by Monitoring Type:
Breakup by Application:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being DePuy Synthes (Johnson & Johnson), HeadSense Medical Ltd., Integra Lifesciences Corporation, LINET Ltd., Medtronic plc, Natus Medical Incorporated, Raumedic AG (Rehau), Sophysa, Spiegelberg Gmbh (SHS), etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Technology, Monitoring Type, Application, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||DePuy Synthes (Johnson & Johnson), HeadSense Medical Ltd., Integra Lifesciences Corporation, LINET Ltd., Medtronic plc, Natus Medical Incorporated, Raumedic AG (Rehau), Sophysa and Spiegelberg Gmbh (SHS)|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at